Maiden Biosciences, Inc.

Maiden Biosciences, Inc. is a U.S.-based biotechnology company specializing in the distribution of FDA-cleared, prescription-only topical collagen wound dressings. Founded in 2016, the company manufactures advanced collagen-based products engineered to manage exudate absorption while maintaining optimal moist wound environments. Their product portfolio includes collagen sheet dressings, collagen powder dressings, and secondary silicone foam dressings. These dressings are clinically indicated for chronic wounds (diabetic foot ulcers, venous leg ulcers, pressure ulcers), acute wounds (burns), surgical wounds (post-operative sites), and traumatic wounds (abrasions, lacerations). The dressings feature a 10-year shelf life and are designed to support natural tissue regeneration, reduce scarring, and minimize pain during dressing changes. Maiden Biosciences targets healthcare professionals and institutional buyers seeking bioactive collagen solutions for superior wound healing outcomes.